The mean serum BSP levels in individuals with BM were significantly higher than those recorded in non-BM NSCLC and controls (p<0.001). The cut-off value was 33.56 ng/ml, and sensitivity and specificity values were 77.8% and 81.1%, respectively. This evidence concerns the gene IBSP and non-small cell lung carcinoma.